Meletios Therapeutics SAS
RCS Lyon 883 003 691
Share capital 3201,20€
24 rue Jean Baldassini
13 rue Monsigny
Editor of the website
Catherine Martre, CEO
Hosting of the website
SAS au capital social de 140 883,49 €
RCS Paris B 847 727 914
Code APE : 7010Z
N° TVA : FR21847727914
Siège social : 63 BD MASSENA 75013 PARIS
Your privacy is important to us. It is Meletios Therapeutics’ policy to respect your privacy and comply with any applicable law and regulation regarding any personal information we may collect about you, including across our website, https://meletiostx.com.
This policy is effective as of 16 April 2021 and was last updated on 21 June 2021.
We use “cookies” to collect information about you and your activity across our site. A cookie is a small piece of data that our website stores on your computer, and accesses each time you visit, so we can improve your experience on our website.
Limits of Our Policy
Our website may link to external sites that are not operated by us. Please be aware that we have no control over the content and policies of those sites and cannot accept responsibility or liability for their respective privacy practices.
Changes to This Policy
If required by law, we will get your permission or give you the opportunity to opt in to or opt out of, as applicable, any new uses of your personal information.
For any questions or concerns regarding your privacy, you may contact us using the following details: